Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
group | 0.100 | None | 1.000 | 82 | 0 | 1975 | 2020 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.100 | None | 0.885 | 26 | 2 | 1975 | 2019 | |||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 0.964 | 168 | 0 | 1976 | 2020 | ||||||||
|
cytochrome c oxidase subunit 8A | 0.400 | 0.846 | 0.12 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1977 | 2019 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.875 | 16 | 2 | 1977 | 2019 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1977 | 1977 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.100 | None | 0.957 | 46 | 0 | 1978 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1978 | 1978 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.100 | None | 0.945 | 91 | 3 | 1979 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.100 | None | 0.976 | 41 | 8 | 1979 | 2020 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
group | 0.100 | None | 0.947 | 19 | 1 | 1979 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
group | 0.100 | None | 0.944 | 18 | 1 | 1979 | 2020 | ||||||||
|
cytochrome P450 family 3 subfamily A member 7 | 0.670 | 0.500 | 6.1E-14 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1979 | 2019 | ||||||||
|
CYP3A7-CYP3A51P readthrough | 0.821 | 0.154 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 1979 | |||||||||
|
amine oxidase copper containing 1 | 0.628 | 0.769 | 6.7E-08 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 2018 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.944 | 304 | 9 | 1980 | 2020 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.100 | None | 0.977 | 44 | 0 | 1980 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.100 | None | 0.984 | 62 | 0 | 1981 | 2020 | ||||||||
|
beta-2-microglobulin | 0.447 | 0.846 | 0.56 |
|
group | 0.100 | None | 0.900 | 10 | 0 | 1981 | 2019 | ||||||||
|
lamin B receptor | 0.473 | 0.808 | 0.18 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1981 | 2018 | ||||||||
|
arylsulfatase B | 0.595 | 0.692 | 7.0E-09 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 1981 | 2018 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1982 | 2019 | ||||||||
|
BMS1 pseudogene 20 | 0.682 | 0.577 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1982 | 1999 | |||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.400 | None | 0.992 | 128 | 0 | 1983 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.955 | 89 | 8 | 1983 | 2019 |